Poor adherence associated with disruptive life events in young people living with HIV
Injectable PrEP offers superior efficacy to oral PrEP in clinical trial
Has someone been cured of HIV with a cheap, simple drug regimen?
Recycling tenofovir better than switch to second-line zidovudine
Switch to dolutegravir raises the risk of potentially harmful weight gain, four-country African study finds
Islatravir plus doravirine maintains viral suppression for a year
Truvada lawsuit ads are prompting some young people with a high risk of HIV not to start or discontinue PrEP
Rapid weight gain after switching to TAF, regardless of other HIV drugs taken
People with HIV gain weight faster than HIV-negative people
